Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor–Targeted Therapy |
| |
摘 要: |
|
收稿时间: | 12 July 2017 |
本文献已被 ScienceDirect 等数据库收录! |
|